Statistical variation in progressive scrambling
暂无分享,去创建一个
[1] Matthew Clark,et al. Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases , 1990 .
[2] Douglas M. Hawkins,et al. The Problem of Overfitting , 2004, J. Chem. Inf. Model..
[3] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[4] D. Lesieur,et al. Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis. , 2001, Journal of medicinal chemistry.
[5] Douglas M. Hawkins,et al. Assessing Model Fit by Cross-Validation , 2003, J. Chem. Inf. Comput. Sci..
[6] Abby L. Parrill,et al. Rational drug design : novel methodology and practical applications , 1999 .
[7] Robert D. Clark,et al. Boosted leave-many-out cross-validation: the effect of training and test set diversity on PLS statistics , 2003, J. Comput. Aided Mol. Des..
[8] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[9] Han van de Waterbeemd,et al. Chemometric Methods in Molecular Design: van de Waterbeemd/Chemometric , 1995 .
[10] K. Baumann,et al. A systematic evaluation of the benefits and hazards of variable selection in latent variable regression. Part II. Practical applications , 2002 .
[11] Juan M. Luco,et al. QSAR Based on Multiple Linear Regression and PLS Methods for the Anti-HIV Activity of a Large Group of HEPT Derivatives , 1997, J. Chem. Inf. Comput. Sci..
[12] David R. Lowis. Molecular Hologram QSAR , 1999 .
[13] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[14] Hilko van der Voet,et al. Pseudo-degrees of freedom for complex predictive models: the example of partial least squares , 1999 .
[15] C. Monneret,et al. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition. , 1997, Journal of medicinal chemistry.
[16] John H. Kalivas,et al. QSAR modeling based on the bias/variance compromise: a harmonious , 2004, J. Comput. Aided Mol. Des..
[17] Bruce L. Bush,et al. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA , 1993, J. Comput. Aided Mol. Des..
[18] Johann Gasteiger,et al. Neural networks in chemistry and drug design , 1999 .